Cited by CrossRef (71)
- Yung-Chih Kuo, Rajendiran Rajesh. Current development of nanocarrier delivery systems for Parkinson's disease pharmacotherapy. Journal of the Taiwan Institute of Chemical Engineers 2018;87:15
- Sara Hernando, Enara Herran, Rosa Maria Hernandez, Manoli Igartua. Nanostructured Lipid Carriers Made of Ω-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases. Pharmaceutics 2020;12:928
- Raj Kumar, Keshaw Ram Aadil, Kunal Mondal, Yogendra Kumar Mishra, David Oupicky, Seeram Ramakrishna, Ajeet Kaushik. Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology. Critical Reviews in Biotechnology 2022;42:1180
- Ramesha Hanumanthappa, Aravind Parthasarathy, Geetha B. Heggannavar, Kiran PC, Hemalatha Nanjaiah, Ramhari Kumbhar, Kuramkote Shivanna Devaraju. Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein/peptide co‐modified polymer nanoparticles. Neuroprotection 2024
- Sara Hernando, Enara Herran, Jose Luis Pedraz, Manoli Igartua, Rosa Maria Hernandez. Drug and Gene Delivery to the Central Nervous System for Neuroprotection. 2024.
- Vinit V. Agnihotri, Ashish P. Gorle, Chandrakantsing V. Pardeshi, Sanjay J. Surana. Direct Nose-to-Brain Drug Delivery. 2024.
- Mohamed Salama, Mahmoud Sobh, Mahmoud Emam, Ahmed Abdalla, Dina Sabry, Mohamed El-Gamal, Ahmed Lotfy, Mahmoud El-Husseiny, Mohamed Sobh, Ali Shalash, Wael My Mohamed. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease. 2017;13:976
- Weiyuan Zhang, Wenyue Wang, David X Yu, Zhicheng Xiao, Zhiyong He. Application of Nanodiagnostics and Nanotherapy to CNS Diseases. Nanomedicine (Lond.) 2018;13:2341
- Abhijeet D. Kulkarni, Yogesh H. Vanjari, Karan H. Sancheti, Veena S. Belgamwar, Sanjay J. Surana, Chandrakantsing V. Pardeshi. Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review. Journal of Drug Targeting 2015;23:775
- Héctor Hernández-Parra, Hernán Cortés, José Arturo Avalos-Fuentes, María Del Prado-Audelo, Benjamín Florán, Gerardo Leyva-Gómez, Javad Sharifi-Rad, William C. Cho. Repositioning of drugs for Parkinson’s disease and pharmaceutical nanotechnology tools for their optimization. J Nanobiotechnol 2022;20
- Sreekanth Sreekumaran, Anitha Radhakrishnan, Sanju P. Joy. Regenerated Organs. 2022.
- Priyadarshini Mohapatra, Mohanraj Gopikrishnan, George Priya Doss C, Natarajan Chandrasekaran. How Precise are Nanomedicines in Overcoming the Blood–Brain Barrier? A Comprehensive Review of the Literature. IJN 2024;Volume 19:2441
- Piyong Sola, Praveen Krishnamurthy, Pavan Kumar Chintamaneni, Sai Kiran S.S Pindiprolu, Mamta Kumari. Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management. Expert Opinion on Drug Delivery 2020;17:1119
- Sonja Rittchen, Amanda Boyd, Alasdair Burns, Jason Park, Tarek M. Fahmy, Su Metcalfe, Anna Williams. Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF). Biomaterials 2015;56:78
- Juna Brigit Chacko, Sajan Jose. Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery. 2015.
- Sara Hernando, Edorta Santos‐Vizcaíno, Manoli Igartua, Rosa Maria Hernandez. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease. WIREs Nanomed Nanobiotechnol 2023;15
- Kyung Min Chung, Nancy Hernández, Andrew A. Sproul, Wai Haung Yu. Alzheimer’s disease and the autophagic-lysosomal system. Neuroscience Letters 2019;697:49
- Haifa Alkhalifa, Esraa Alshebber, Sebastien Taurin. Theory and Applications of Nonparenteral Nanomedicines. 2019.
- Sema Arisoy, Tansel Comoglu. Effect of Formulation Variables for the Production of WGA-Grafted, Levodopa-Loaded PLGA Nanoparticles. JBBBE 2022;54:1
- Jyotsna Shankar, Geetha K.M, Barnabas Wilson. Potential applications of nanomedicine for treating Parkinson's disease. Journal of Drug Delivery Science and Technology 2021;66:102793
- Ramesh Duwa, Jee-Heon Jeong, Simmyung Yook. Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson’s disease. J. Pharm. Investig. 2021;51:465
- William C. Ballance, Ellen C. Qin, Hee Jung Chung, Martha U. Gillette, Hyunjoon Kong. Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. Biomaterials 2019;217:119292
- Ankit Tandon, Sangh J. Singh, Rajnish K. Chaturvedi. Nanomedicine against Alzheimer’s and Parkinson’s Disease. CPD 2021;27:1507
- Artem Minalyan, Lilit Gabrielyan, Claudio Pietra, Yvette Taché, Lixin Wang. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson’s Disease in Male Rats. Front. Integr. Neurosci. 2019;13
- Urba Afnan, Mohamad Sultan Khan, C.A. Swaliha, Umar Manzoor, Ibtisam Mumtaz, Mohd Jamal Dar, Tariq Maqbool. Phospholipases in Physiology and Pathology. 2019.
- Andrea Vaquero-Rodríguez, Jone Razquin, Maider Zubelzu, Raphaelle Bidgood, Harkaitz Bengoetxea, Cristina Miguelez, Teresa Morera-Herreras, Jose Angel Ruiz-Ortega, José Vicente Lafuente, Naiara Ortuzar. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B. 2019.
- Gerardo Leyva-Gómez, Hernán Cortés, Jonathan J. Magaña, Norberto Leyva-García, David Quintanar-Guerrero, Benjamín Florán. Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain. Drug Discovery Today 2015;20:824
- Fatemeh Khatami. Neural Regenerative Nanomedicine. 2015.
- Zi-Hua Guo, Saadullah Khattak, Mohd Ahmar Rauf, Mohammad Azam Ansari, Mohammad N. Alomary, Sufyan Razak, Chang-Yong Yang, Dong-Dong Wu, Xin-Ying Ji. Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders. Molecules 2023;28:1283
- Emile F. van Vliet, Maarten J. Knol, Raymond M. Schiffelers, Massimiliano Caiazzo, Marcel H.A.M. Fens. Levodopa-loaded nanoparticles for the treatment of Parkinson's disease. Journal of Controlled Release 2023;360:212
- Pratik Chakraborty, Chiranjib Bhattacharyya, Ranabir Sahu, Tarun K. Dua, Ramesh Kandimalla, Saikat Dewanjee. Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 2024;91:105267
- Iman Fatemi, Sara Heydari, Ayat Kaeidi, Ali Shamsizadeh, Elham Hakimizadeh, Amin Khaluoi, Mohammad Allahtavakoli. Metformin ameliorates the age‐related changes of d‐galactose administration in ovariectomized mice. Fundamemntal Clinical Pharma 2018;32:392
- C. Rodríguez-Nogales, E. Garbayo, M.M. Carmona-Abellán, M.R. Luquin, M.J. Blanco-Prieto. Brain aging and Parkinson’s disease: New therapeutic approaches using drug delivery systems. Maturitas 2016;84:25
- Miguel Pinto, Vera Silva, Sandra Barreiro, Renata Silva, Fernando Remião, Fernanda Borges, Carlos Fernandes. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Research Reviews 2022;79:101658
- Kunjbihari Sulakhiya, Anglina Kisku, Rishi Paliwal, Deepak K Gupta, Yashraj Yadav, Ajay Pal, Suneel Kumar. Nanotechnology for Drug Delivery and Pharmaceuticals. 2022.
- Sema Arisoy, Ozgun Sayiner, Tansel Comoglu, Deniz Onal, Ozbeyen Atalay, Bilge Pehlivanoglu. In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery. Pharmaceutical Development and Technology 2020;25:735
- Sourav De, Yung-Chih Kuo. Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease. Journal of the Taiwan Institute of Chemical Engineers 2024;157:105401
- Ankit Shokeen, Bhavya Dhawan, Maryam Sarwat, Sangeetha Gupta. Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic Diseases. 2024.
- Barry Boland, Wai Haung Yu, Olga Corti, Bertrand Mollereau, Alexandre Henriques, Erwan Bezard, Greg M. Pastores, David C. Rubinsztein, Ralph A. Nixon, Michael R. Duchen, Giovanna R. Mallucci, Guido Kroemer, Beth Levine, Eeva-Liisa Eskelinen, Fanny Mochel, Michael Spedding, Caroline Louis, Olivier R. Martin, Mark J. Millan. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov 2018;17:660
- Phuong-Trang Nguyen-Thi, Thanh-Tam Ho, Thuy Trang Nguyen, Giau Van Vo. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's
Diseases. CDD 2024;21:917
- PSS Rao, Christopher RT Stang. Advances in Personalized Nanotherapeutics. 2024.
- Lihua Zhang, Lulu Pang, Siqing Zhu, Jinqiu Ma, Ruiteng Li, Yijing Liu, Lin Zhu, Xiaomei Zhuang, Weijia Zhi, Xiang Yu, Lina Du, Hongyan Zuo, Yiguang Jin. Intranasal tetrandrine temperature-sensitive in situ hydrogels for the treatment of microwave-induced brain injury. International Journal of Pharmaceutics 2020;583:119384
- Arun Kumar Kotha, Saikat Ghosh, Neeraja Komanduri, Rui Wang, Subhas Bhowmick, Mahavir Bhupal Chougule. Novel Drug Delivery Technologies. 2020.
- Hitesh Malhotra, Rupesh K. Gautam. Block Co-polymeric Nanocarriers: Design, Concept, and Therapeutic Applications. 2020.
- Abdul Waris, Asmat Ali, Atta Ullah Khan, Muhammad Asim, Doaa Zamel, Kinza Fatima, Abdur Raziq, Muhammad Ajmal Khan, Nazia Akbar, Abdul Baset, Mohammed A. S. Abourehab. Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders. Nanomaterials 2022;12:2140
- Jonathan Baskin, June Evelyn Jeon, Simon J. G. Lewis. Nanoparticles for drug delivery in Parkinson’s disease. J Neurol 2021;268:1981
- Nelofer Ereej, Huma Hameed, Mahtab Ahmad Khan, Saleha Faheem, Anam Hameed. Nanoparticle-based Gene Therapy for Neurodegenerative Disorders. MRMC 2024;24:1723
- Juhi Samal, Ana Lucia Rebelo, Abhay Pandit. A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders. Advanced Drug Delivery Reviews 2019;148:68
- Nicolò Montegiove, Eleonora Calzoni, Carla Emiliani, Alessio Cesaretti. Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases. JFB 2022;13:125
- Thuy Trang Nguyen, Phuong-Trang Nguyen-Thi, Thi Hong Anh Nguyen, Thanh-Tam Ho, Nguyen-Minh-An Tran, Toi Van Vo, Giau Van Vo. Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders. Mol Diagn Ther 2023;27:457
- Chhavi Bhalothia, Girima Nagda. Nanotherapeutics a promising approach for treatment of Parkinson’s disease. Materials Today: Proceedings 2022;69:A1
- Ankit Shah, Muzammil Kuddushi, Kulsum Mondal, Monika Jain, Naved Malek. Magnetically driven release of dopamine from magnetic-non-magnetic cellulose beads. Journal of Molecular Liquids 2020;320:114290
- Zhiren Wang, Karina Marie Gonzalez, Leyla Estrella Cordova, Jianqin Lu. Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases. WIREs Nanomed Nanobiotechnol 2023;15
- Amanda Cano, Elena Sánchez-López, Miren Ettcheto, Ana López-Machado, Marta Espina, Eliana B Souto, Ruth Galindo, Antonio Camins, Maria Luisa García, Patric Turowski. Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases. Nanomedicine (Lond.) 2020;15:1239
- Naumih M. Noah, Peter M. Ndangili. Polymeric Nanosystems. 2020.
- Julie Tzu‐Wen Wang, Ana C. Rodrigo, Anna K. Patterson, Kirsten Hawkins, Mazen M. S. Aly, Jia Sun, Khuloud T. Al Jamal, David K. Smith. Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self‐Healing Supramolecular Gel. Advanced Science 2021;8
- K. Radhakrishnan, P. Senthil Kumar, Gayathri Rangasamy, K. Ankitha, V. Niyathi, V. Manivasagan, K. Saranya. Recent advances in nanotechnology and its application for neuro-disease: a review. Appl Nanosci 2023;13:6631
- Emre Uygur, Kadriye Büşra Karatay, Emine Derviş, Vedat Evren, Ayfer Yurt Kılçar, Özge Kozguş Güldü, Ceren Sezgin, Burcu Acar Çinleti, Volkan Tekin, Fazilet Zumrut Biber Muftuler. Synthesis of Novel Plant-Derived Encapsulated Radiolabeled Compounds for the Diagnosis of Parkinson’s Disease and the Evaluation of Biological Effects with In Vitro/In Vivo Methods. Mol Neurobiol 2024;61:8851
- Stalin Kondaveeti, Daniel R. Cornejo, Denise Freitas Siqueira Petri. Alginate/magnetite hybrid beads for magnetically stimulated release of dopamine. Colloids and Surfaces B: Biointerfaces 2016;138:94
- Paramita Saha, Himanshu Kathuria, Murali Monohar Pandey. Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease. Journal of Controlled Release 2023;358:293
- Lina Zhou, Sandip Godse, Namita Sinha, Sunitha Kodidela, Udai Singh, Santosh Kumar. Darunavir Nanoformulation Suppresses HIV Pathogenesis in Macrophages and Improves Drug Delivery to the Brain in Mice. Pharmaceutics 2024;16:555
- Banu Cahide Tel, Gul Yalçin Çakmakli. Nanotechnology Methods for Neurological Diseases and Brain Tumors. 2024.
- Mehdi Bazi Alahri, Alhawarin Jibril Ibrahim, Mahmood Barani, Hassan Arkaban, Seyedeh Malahat Shadman, Soodeh Salarpour, Payam Zarrintaj, Javad Jaberi, Abduladheem Turki Jalil. Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform. Molecules 2023;28:841
- Gabriel Henrique Hawthorne, Marcelo Picinin Bernuci, Mariza Bortolanza, Vitor Tumas, Ana Carolina Issy, Elaine Del-Bel. Nanomedicine to Overcome Current Parkinson’s Treatment Liabilities: A Systematic Review. Neurotox Res 2016;30:715
- Sankalp A. Gharat, Munira M. Momin, Tabassum Khan. Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications. 2016.
- Richa Pahuja, Kavita Seth, Anshi Shukla, Rajendra Kumar Shukla, Priyanka Bhatnagar, Lalit Kumar Singh Chauhan, Prem Narain Saxena, Jharna Arun, Bhushan Pradosh Chaudhari, Devendra Kumar Patel, Sheelendra Pratap Singh, Rakesh Shukla, Vinay Kumar Khanna, Pradeep Kumar, Rajnish Kumar Chaturvedi, Kailash Chand Gupta. Trans-Blood Brain Barrier Delivery of Dopamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Rats. ACS Nano 2015;9:4850
- Ajit Singh, Sandeep Kumar Maharana, Rahul Shukla, Prashant Kesharwani. Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease. Process Biochemistry 2021;110:181
- Abrar M. Khan, Farhan Jalees Ahmad, Amulya K. Panda, Sushama Talegaonkar. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies. International Journal of Pharmaceutics 2016;507:61
- You Jung Kang, Eric Gerard Cutler, Hansang Cho. Therapeutic nanoplatforms and delivery strategies for neurological disorders. Nano Convergence 2018;5
- Javeria Fatima, Yasir Hasan Siddique. Application of Nanocomposites and Nanoparticles in Treating
Neurodegenerative Disorders. CNSNDDT 2024;23:1217
- Francisca Espinoza, Walther Ide, Natalia Saldivia, Diego Zelada. Polymeric Biomaterials for Healthcare Applications. 2024.